top of page

NACCCA Scientific Development Webinar Series in September: Prenatal Screening for Preterm Preeclampsia

Tue, Sep 26

|

Zoom Webinar

Geralyn Messerlian, PhD, FAACC Professor of Pathology and Laboratory Medicine Professor of Obstetrics and Gynecology CNE Director of Chemistry and Special Chemistry Women and Infants Hospital Alpert Medical School at Brown University Providence, RI, USA

Registration is closed
See other events
NACCCA Scientific Development Webinar Series in September: Prenatal Screening for Preterm Preeclampsia
NACCCA Scientific Development Webinar Series in September: Prenatal Screening for Preterm Preeclampsia

Time & Location

Sep 26, 2023, 1:00 PM – 2:00 PM EDT

Zoom Webinar

About This Event

Watch Webinar Video Here

Geralyn Lambert-Messerlian PhD, FAACC earned her degree in Endocrinology at Boston University and completed her post-doctoral training in Reproductive Endocrinology at the Massachusetts General Hospital/Harvard University. She currently serves as Director of Medical Screening and Special Testing at Women and Infants Hospital and Director of Chemistry at Care New England. Her research is focused on the development and application of serum biomarkers for women’s health, particularly in the areas of fertility, pregnancy, prenatal screening, and gynecologic cancers.  

Learning objectives

At the end of this activity, participants will be able to:

1. Define maternal and fetal risks associated with preeclampsia

2. Describe the first trimester multiple marker screening test to assess preeclampsia risk

3. Discuss the benefits and limitations of low dose aspirin for prevention

Share this event

bottom of page